Dr. Global Clinical Lead, MD
Claim this profileStudies Endometrial Cancer
Studies Biliary Tract Cancer
1 reported clinical trial
9 drugs studied
Clinical Trials Global Clinical Lead, MD is currently running
More about Global Clinical Lead, MD
Clinical Trial Related2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical TrialTreatments Global Clinical Lead, MD has experience with
- 5-Fluorouracil
- AZD5305
- Bevacizumab
- Capecitabine
- Carboplatin
- Datopotamab Deruxtecan (Dato-DXd)
Breakdown of trials Global Clinical Lead, MD has run
Endometrial Cancer
Biliary Tract Cancer
Prostate Cancer
Ovarian Cancer
Colorectal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Global Clinical Lead, MD specialize in?
Global Clinical Lead, MD focuses on Endometrial Cancer and Biliary Tract Cancer. In particular, much of their work with Endometrial Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Global Clinical Lead, MD currently recruiting for clinical trials?
Yes, Global Clinical Lead, MD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Global Clinical Lead, MD has studied deeply?
Yes, Global Clinical Lead, MD has studied treatments such as 5-Fluorouracil, AZD5305, Bevacizumab.
What is the best way to schedule an appointment with Global Clinical Lead, MD?
Apply for one of the trials that Global Clinical Lead, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.